Recruitment

Eingeschlossene Patienten: 23.771 (Stand 01. Oktober 2025)
Amgevita® (Adalimumab)268
Benepali® (Etanercept)1305
Cimzia® (Certolizumab)1062
Enbrel® (Etanercept)2879
Erelzi® (Etanercept)623
Flixabi® (Infliximab)10
Hukyndra® (Adalimumab)18
Hulio® (Adalimumab)309
Humira® (Adalimumab)2912
Hyrimoz® (Adalimumab)285
Idacio® (Adalimumab)73
Imraldi® (Adalimumab)248
Inflectra™ (Infliximab)16
Jyseleca® (Filgotinib)187
Kevzara® (Sarilumab)243
Kineret® (Anakinra)89
MabThera® (Rituximab)1459
Nepexto® (Etanercept)106
Olumiant® (Baricitinib)564
Orencia® (Abatacept)1000
Remicade® (Infliximab)762
Remsima® (Infliximab)27
Rinvoq® (Upadacitinib)354
Rixathon® (Rituximab)20
RoActemra® (Tocilizumab)1381
Ruxience® (Rituximab)1
Simponi® (Golimumab)481
Truxima® (Rituximab)8
Tyenne® (Tocilizumab)73
Xeljanz® (Tofacitinib)404
Yuflyma® (Adalimumab)73
Zessly® (Infliximab)2
Kontrollen6529